LEADER 01587oam  2200409 a 450 
001 9910697089303321
005 20230902161738.0
035   $a(CKB)5470000002384005
035   $a(OCoLC)539537379
035   $a(EXLCZ)995470000002384005
100   $a20100304d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicaid outpatient prescription drugs$b[electronic resource] $esecond quarter 2008 federal upper limits for reimbursement compared with average retail pharmacy acquisition costs : [letter to Charles E. Grassley, Ranking Member, Committee on Finance, United States Senate /$fJohn E. DIcken]
210  1$aWashington, DC :$cU.S. Govt. Accountability Office,$d[2009]
215   $a1 online resource (33 pages) $cillustrations
300   $aTitle from PDF caption title screen (GAO, viewed March 4, 2010).
300   $a"November 30, 2009."
300   $a"GAO-10-118R."
320   $aIncludes bibliographical references.
517   $aMedicaid outpatient prescription drugs 
606   $aMedicaid
606   $aPharmaceutical services insurance$xEconomic aspects
615  0$aMedicaid.
615  0$aPharmaceutical services insurance$xEconomic aspects.
700   $aDicken$b John E$01382684
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910697089303321
996   $aMedicaid outpatient prescription drugs$93446157
997   $aUNINA